Calling external auditors of loss making penny stocks
External auditors have a big role to play to ensure companies do not cheat shareholders by hiding potential red flags from the audit report.
If Serbadk can sue KPMG for trying to raise potential red flags then shareholders must also be able to sue auditors for trying to hide potential red flags.
Pasukhas and Fintec in glove venture. This is classic news. Two zombies company trying to revive itself. Glove outdate d lo, should venture into Space with NASA engine oil.
kilang glove extend.janji kosong.buat new pandai,wang Sudah pakai kosong.material tak mampu beli.jauhkan counter scam ini.kena gigit surupa covid pun tak tau apahal.
Already invested in AT glove with 38% holding, mau buat glove factory lagi.itu AT glove factory, belum untung, share price sudah jatuh kaw;kaw mau wayang lagi ka ..gila punya olang..
Huge loss is understood, that is the purpose to raise funds to meet needs including losses. Excel in gloves business is unlikely but objective is to tender building gloves factory.
Interesting. A very successful story on funds raising. Consolidation is possible on argument to reduce number of shares and for further price dropping opportunities as in the case of sanichi etc. Will be great if investors know what cars bod and management driving and what type of houses they are staying.
Bursa pun ada salah lah.....senang sangat approve company ESOS share.......semua ular,.......Fintec,Vsolar,Lambo...n more penny counter ,everyday in most top 30 active counters....juat made volume ,but price price same.
Elitetrader...i support u said.....last year market is hot.....many penny counters big volume....i bought Fintec 50000 units...0.145...juat want made some money for kopi n roti.....kfc;...after two month Fintec announce....right issue n gif warrant.....i cut loss all ,sold 0.13 cts......after this i don;t buy anymore penny stock already...surrender.
AT SYSTEMATIZATION BERHAD [Registration No. 200401006297 (644800-X)] Explanatory Notes Pursuant to the Listing Requirements For 12 Months Ended 31 March 2021 P a g e | 21 B3) Prospects (Cont’d) Glove business The Group has completed the commissioning of 3 production lines in Chemor Plant during the financial year end 31 March 2021. Since then, the Group has further completed additional 3 production lines and is now running 6 glove dipping lines with an annual capacity of 0.88 billion pieces of gloves. The Group is currently building 4 production lines concurrently and scheduled for completion progressively between now and end of September/October 2021. Barring any unforeseen circumstances, upon completion of these additional 4 production lines, the Group will have a total 10 production lines with an annual capacity of 1.5 billion pieces of medical gloves. Production and sales quantity is expected to rise with additional production lines completed progressively. Thus far, the Group has obtained the following certifications, licenses and qualifications: - • CE Marking Certification - typically recognised in the European region for the export of its medical examination gloves. • Establishment Registration with Food and Drug Administration of the United States (“FDA”), which allow the Group to export its medical gloves to the United States. • EN374 test standard: Protective gloves against chemicals and micro-organisms. • Medical Device Authority license which allows the Group to manufacture, distribute and sell our gloves locally. • ISO9001 & ISO13485 certifications. The Group is in the midst of applying 510(K) approval from FDA and target to obtain it by 2021. Capitalising the above certifications and qualifications, the Group expects strong demand for its gloves. The prospects remain generally good and the Group shall continue to work with strategic partners to lock in commitments for the purchase of gloves. The Group has also completed acquiring a piece of industrial land measuring 72,770 square meters located in Kamunting, Perak on 26 March 2021. Depending on the availability of funds from time to time, the Group intends to install up to 50 production lines in Kamunting. The Group’s venture into the glove business is expected to allow the Group to capitalise on a booming segment with favorable long-term prospects and is expected contribute to the future earnings of the Group as well as improve the Group’s financial performance in the coming years.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
whistlebower99
5,255 posts
Posted by whistlebower99 > 2021-06-25 17:03 | Report Abuse
@Kingston1, Is your information correct?
Will you allow your post to be shared out?